Close search modal
News

Mediwhale wins EU CE MDR approval for retinal AI cardiovascular risk tool

Korea Biomedical Review

Mediwhale said Wednesday that its retinal AI solution, Dr. Noon, has obtained certification under the European Union’s Medical Device Regulation (CE MDR).

There are no previous posts.
Mediwhale secures ₩20 billion in Series C funding, preparing for IPO